Home » Policy
Category Archives: Policy
Executive Director Tom McKeag and board members Meg Schwarzman and Marty Mulvihill will be speaking at the ChemicalWatch Safer Chemicals in Products conference in San Francisco, on March 27 and 28. Tom will be speaking about our Greener Solutions course and how BCGC partners with industry, Meg will lead a panel discussion on alternatives assessment, and Marty will discuss the motivation of funders and how they might drive innovation.
The event will offer expert panels and case studies of best practices to achieve safer chemical choices in products. Throughout the two days attendees will examine the interplay between regulation and safer chemicals with the business benefits of progressive safe chemicals management through the supply chain.
Learn more about the event here: https://chemicalwatch.com/safer-chemicals-products-2017
A big part of implementing green chemistry in industry is the task of identifying and selecting product or process chemistries that are safer, less resource-intensive, and also functionally better than those we currently use. That involves complex judgments and comparisons with many dimensions. Figuring out how to make multifaceted comparisons to support scientifically informed judgments is the domain of alternatives assessment (AA). Anyone involved in green chemistry should be familiar with this idea.
Chemical Footprinting: Identifying Hidden Liabilities in Manufacturing Consumer Products
In an unassuming low-rise in the Boston suburbs, Mark Rossi tinkers with a colorful dashboard on his laptop screen while his border collie putters around his feet. Rossi is the founder of BizNGO and Clean Production Action, two nonprofit collaborations of business and environmental groups to promote safer chemicals. He’s also the creator of tools that he hopes will solve a vexing problem—how to get a handle on companies’ overall toxic chemicals usage.
Consider the screen of Rossi’s laptop. Chances are the company that manufactured the product has crunched the numbers on the total amount of carbon, water, and land associated with getting it into the office—from the manufacturing of the electronic components to the packaging and transportation to retail outlets. But the total amount of toxic chemicals that contributed to the screen’s design and production might be a more difficult question to answer….
Read the entire story, by Lindsey Konkel, at http://ehp.niehs.nih.gov/123-a130/
An international panel of scientists has found that endocrine disrupting chemicals likely cost the European Union over 100 billion dollars annually — and American officials say this expense could be even higher in the U.S.
The scientific panel, convened by the Endocrine Society, adopted strategies created by the Intergovernmental Panel on Climate Change to evaluate how much causation of a particular disorder could be attributed to a particular chemical. For example, they found 70-100% probability that polybrominated diphenyl ether (PBDE) and organophosphates contribute to IQ loss, based on previously published epidemiological studies. They then estimated the costs incurred to the European Union from health issues caused by exposure to endocrine disrupting chemicals. The health effects investigated included neurobehavioral disorders, male reproductive health issues, and diabetes, and the total cost was found to be at least 100 billion dollars.